NewSquare Capital’s Imunon IMNN Stock Holding History

NewSquare Capital’s Portfolio IMNN Stock Details IMNN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-1	Closed	-$13	–	734
2023 Q2	$13	Hold	1	–	–	﹤0.01%	842
2023 Q1	$12	Buy	+1	New	+$19	﹤0.01%	874

Other funds holding IMNN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

MRCM

M&R Capital Management Summit, New Jersey $454M AUM 40.11% 1-Year Est. Return

NewSquare Capital's IMNN Position: Q3 2023 in Review

NewSquare Capital sold out of Imunon (IMNN) in Q3 2023, closing a stake of 1 share — an estimated $13 sold.

NewSquare Capital first reported a position in IMNN in Q1 2023 and held it in 2 quarters. The position peaked at $13 in Q2 2023. 15 funds tracked by Wall St. Rank hold IMNN as of Q3 2023.

NewSquare Capital reported no remaining Imunon position as of Q3 2023 after selling out during the quarter.
NewSquare Capital sold 1 Imunon share in Q3 2023, an estimated $13.
NewSquare Capital first reported a position in Imunon in Q1 2023 and held it in 2 quarters.
NewSquare Capital's Imunon position peaked at $13 in Q2 2023.
15 funds tracked by Wall St. Rank held Imunon as of Q3 2023.

Based on NewSquare Capital's 13F filing for Q3 2023, filed 3 Nov 2023.